摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tetradecylsulfinylacetic acid | 13887-88-2

中文名称
——
中文别名
——
英文名称
tetradecylsulfinylacetic acid
英文别名
2-(tetradecylsulfinyl)acetic acid;tetradecylsulfoxyacetic acid;Acetic acid, (tetradecylsulfinyl)-;2-tetradecylsulfinylacetic acid
tetradecylsulfinylacetic acid化学式
CAS
13887-88-2
化学式
C16H32O3S
mdl
——
分子量
304.494
InChiKey
UNMRRTSXKVMTER-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    90 °C
  • 沸点:
    476.6±28.0 °C(Predicted)
  • 密度:
    1.026±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    20
  • 可旋转键数:
    15
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    73.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-四氢糠胺tetradecylsulfinylacetic acid磷酸 作用下, 反应 1.5h, 以60%的产率得到2-(tetradecylsulfinyl)-N-((tetrahydrofuran-2-yl)methyl)acetamide
    参考文献:
    名称:
    一种含亚砜基金属萃取剂及其制备方法
    摘要:
    本发明公开了一种含亚砜基金属萃取剂及其制备方法。该含亚砜基金属萃取剂为2‑(烷基亚磺酰基)‑N‑((四氢呋喃‑2‑基)甲基)乙酰胺。该制备方法以硫醇为原料,在碱性条件下和氯乙酸反应生成对应的硫醚,然后在有机酸环境下经双氧水氧化得到亚砜,亚砜在强酸性高温条件下与2‑四氢糠胺反应,生成对应的酰胺。本发明的含亚砜基金属萃取剂对环境和生物体的安全性高、低毒、润湿性好、起泡力强、易生物降解,在弱酸性条件下对稀土金属铥、镱、镥有很好的萃取效果。
    公开号:
    CN106478557B
  • 作为产物:
    描述:
    正十四烷基硫醇双氧水溶剂黄146 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 2.67h, 生成 tetradecylsulfinylacetic acid
    参考文献:
    名称:
    一种含亚砜基金属萃取剂及其制备方法
    摘要:
    本发明公开了一种含亚砜基金属萃取剂及其制备方法。该含亚砜基金属萃取剂为2‑(烷基亚磺酰基)‑N‑((四氢呋喃‑2‑基)甲基)乙酰胺。该制备方法以硫醇为原料,在碱性条件下和氯乙酸反应生成对应的硫醚,然后在有机酸环境下经双氧水氧化得到亚砜,亚砜在强酸性高温条件下与2‑四氢糠胺反应,生成对应的酰胺。本发明的含亚砜基金属萃取剂对环境和生物体的安全性高、低毒、润湿性好、起泡力强、易生物降解,在弱酸性条件下对稀土金属铥、镱、镥有很好的萃取效果。
    公开号:
    CN106478557B
点击查看最新优质反应信息

文献信息

  • Therapeutic use of acyl glycerols and the nitrogen- and sulphur- containing analogues thereof
    申请人:Darteil Raphael
    公开号:US20060154984A1
    公开(公告)日:2006-07-13
    The invention relates to the use of acyl glycerols and the nitrogen- and sulfur-containing analogues thereof in the therapeutic field, particularly in human health. The inventive compounds have advantageous pharmacological properties and are particularly of use for the prevention or treatment of neurodegenerative diseases.
    这项发明涉及在治疗领域中使用酰基甘油及其氮和硫含量类似物,特别是在人类健康领域。这些创新化合物具有有益的药理特性,特别适用于预防或治疗神经退行性疾病。
  • Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof
    申请人:Darteil Raphael
    公开号:US20060252827A1
    公开(公告)日:2006-11-09
    The invention relates to the use of acylglycerols and the nitrogen- and sulfur-containing analogues thereof in therapy, particularly for the treatment of cerebral ischemia. The invention further relates to methods for preparing said derivatives, novel compounds, in particular acylglycerols, the nitrogen- and sulfur-containing analogues thereof and methods for preparing same.
    这项发明涉及在治疗中使用酰基甘油和其氮和硫含量类似物,特别是用于治疗脑缺血。该发明还涉及制备这些衍生物的方法,新颖化合物,特别是酰基甘油,其氮和硫含量类似物以及制备它们的方法。
  • Fatty acid compounds, preparation and uses thereof
    申请人:——
    公开号:US20040192908A1
    公开(公告)日:2004-09-30
    The invention concerns novel molecules, their preparation and their uses, in particular in the field of human and veterinary medicine and cosmetics. The inventive compounds are partly fatty acid derivatives and exhibit advantageous pharmacological and cosmetic properties. The invention also concerns various uses of said compounds, the pharmaceutical compositions containing them and methods for preparing them. The inventive compounds are useful in particular for preventing and/or treating dyslipidemiae, cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, certain cancers, dermatological diseases and in cosmetics, for fighting against skin aging and its effects notably against wrinkles and the like
    这项发明涉及新颖分子,它们的制备和用途,特别是在人类和兽医医学以及化妆品领域。这些创新化合物部分是脂肪酸衍生物,并具有有利的药理和化妆品特性。该发明还涉及所述化合物的各种用途,含有它们的药物组合物以及制备它们的方法。这些创新化合物特别适用于预防和/或治疗血脂异常、心血管疾病、X综合征、再狭窄、糖尿病、肥胖、高血压、某些癌症、皮肤病以及在化妆品中,用于对抗皮肤衰老及其影响,尤其是对抗皱纹等。
  • Anti-cancer nitro- and thia-fatty acids
    申请人:——
    公开号:US20030078299A1
    公开(公告)日:2003-04-24
    The present invention relates to pharmaceutical compositions comprising, as an anti-cancer agent: (a) one or more compounds having the formula NO 2 —A—B, 1 wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 double bonds, and B is (CH 2 ) m (COOH) n in which n is a integer from 0 to 2 and m is an integer from 0 to 2; or a derivative thereof in which the hydrocarbon chain has one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy; (b) one or more compounds selected from polyunsaturated fatty acids (PUFA's) having a 16 to 26 carbon atom chain and 3 to 16 double bonds, and wherein the PUFA is covalently coupled at the carboxylic acid group to an amino acid selected from glycine and aspartic acid; (c) one or more compounds selected from unsaturated fatty acids having an 18 to 25 carbon atom chain and 1 to 6 double bonds and wherein the fatty acid has one or two &bgr;-oxa, &ggr;-oxa, &bgr;-thia, &ggr;-thia substitutions: or (d) one or more compounds having formula (I) wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH 2 ) J (COOH) k in which j is an integer from 1 to 3 and K is 0 or 1; or a derivative thereof in which the hydrocarbon chain has one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy; and a pharmaceutically acceptable carrier or diluent.
    本发明涉及制药组合物,包括作为抗癌剂的:(a) 一个或多个具有式NO2—A—B,1的化合物,其中A是14-26个双键的饱和或不饱和碳氢链,B是(CH2)m(COOH)n,其中n是0到2的整数,m是0到2的整数;或其衍生物,其中碳氢链具有羟基、过氧化氢基、环氧基和过氧基中的一种或多种取代;(b) 一种或多种选择自具有16到26个碳原子链和3到16个双键的多不饱和脂肪酸(PUFA),其中PUFA在羧酸基上与选择自甘氨酸和天冬氨酸的氨基酸共价耦合;(c) 一种或多种选择自具有18到25个碳原子链和1到6个双键的不饱和脂肪酸,其中脂肪酸具有一或两个β-氧杂、γ-氧杂、β-硫杂、γ-硫杂取代;或(d) 公式(I)中A′是9-26个碳原子的饱和或不饱和碳氢链,X是氧或不存在,B′是(CH2)J(COOH)k,其中j是1到3的整数,k是0或1;或其衍生物,其中碳氢链具有羟基、过氧化氢基、环氧基和过氧基中的一种或多种取代;以及药学上可接受的载体或稀释剂。
  • Antioxidant Behaviour of Thia Fatty Acids
    作者:C. J. Easton、A. Ferrante、T. A. Robertson、L. Xia
    DOI:10.1071/ch02095
    日期:——

    Eight thia fatty acids and other sulfides have been studied as inhibitors of autoxidation of arachidonic acid. The inhibitors extend the lag phase of the oxidation, to varying degrees. A carboxyl group in the vicinity of the sulfur reduces the antioxidant activity, while unsaturated sulfides are more effective than their saturated analogues. The results are consistent with the sulfides acting to reduce fatty acid hydroperoxides, which otherwise accumulate during the early stages of reaction and propagate the free-radical oxidation process.

    作为花生四烯酸自氧化的抑制剂,对八种脂肪酸和其他硫化物进行了研究。这些抑制剂在不同程度上延长了氧化的滞后期。硫附近的羧基降低了抗氧化活性,而不饱和硫化物比饱和硫化物更有效。这些结果与硫化物减少脂肪酸氢过氧化物的作用是一致的,否则氢过氧化物会在反应的早期阶段积聚并扩展自由基氧化过程。
查看更多